SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Nietzsche who wrote (72638)4/30/1999 1:14:00 PM
From: If only I'd held  Read Replies (1) of 119973
 
DIGE< Let me spell it out for you.

Read the news on this company. If I remember right, I ballparked this product to be worth around a billion dollars in sales or so per year. I can not remember my actual figures. There is the possibility that 50 million of these tests can be sold per year.

"''Of the 50 million Pap smears performed in the United States annually, 3.5 million women are diagnosed with an ASCUS (atypical squamous cells of undetermined significance) or borderline Pap smear results,'' stated Dr. Diane McGrory, Chair, Department of Obstetrics and Gynecology, Dedham Medical Association. ''The approval of Hybrid Capture II in the U.S. means that I can now offer my patients a test that can detect all 13 key cancer-causing types of HPV.''

If the price for this test is only 20 bucks and it is recommended by doctors in addition to all pap smears, $1,000,000,000 bucks. That's right, a billion. My guess is that the test is more than 20 bucks :o)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext